CD163 and COVID-19: Interestingly, CD163‐enriched macrophages were reported to have a pro‐fibrotic phenotype and accumulate in the lungs specifically in areas of fibrotic tissue remodeling in patients with severe COVID‐19‐associated acute respiratory distress syndrome [23].